COMBINED SODIUM FLUORIDE AND CALCIUM CITRATE THERAPY IN OSTEOPOROSIS

氟化钠和柠檬酸钙联合治疗骨质疏松症

• 批准号: 6117518
• 负责人: KHASHAYAR SAKHAEE
• 金额: $ 3.48万
• 依托单位: UT SOUTHWESTERN MEDICAL CENTER
• 依托单位国家: 美国
• 财政年份: 1998
• 资助国家: 美国
• 起止时间: 1998-12-01 至 1999-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6117518
• 关键词: calcium; citrates; clinical research; clinical trials; combination chemotherapy; fluorine; human subject; human therapy evaluation; metabolism disorder chemotherapy; osteoporosis; skeletal disorder chemotherapy; slow release drug; sodium

The purpose is to determine whether or not the amount of bone in persons suffering from osteoporosis can be increased using a combination of slow release sodium fluoride and calcium citrate. Since this is a non-randomized study, only previously entered patients continue to be studied. New patients are entered into the randomized trials underway via sister projects.

目的是确定是否可以使用缓释氟化钠和柠檬酸钙的组合来增加患有骨质疏松症的人的骨量。 由于这是一项非随机化研究，因此仅对之前入组的患者继续进行研究。 新患者通过姐妹项目进入正在进行的随机试验。